About 100 reports

FIGURE ## PHARMACEUTICAL & BIOPHARMACEUTICAL R&D EXPENDITURE, 2017–2024

  • Cell Therapy
  • United States
  • APAC
  • United Kingdom
  • Europe
  • North America
  • Cancer Incidence
  • Health Expenditure

Centaur Biopharmaceutical Services Inc

  • Gene Therapy
  • Cell Therapy
  • World
  • United Kingdom
  • Drug Approval
  • Prescription Drug Sales

##.## Increasing R&D activities in biopharmaceutical companies

  • Biotechnology
  • Biopharmaceutical
  • China
  • United Kingdom
  • APAC
  • United States
  • Cancer Incidence
  • Chronic Disease Prevalence

‘Antibody-Mediated Rejection (AMR) – Market Insights, Epidemiology, and Market Forecast—2030’ report deliver an in-depth understanding of the AMR, historical and forecasted epidemiology as well as the market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The AMR market report provides current...

  • Epidemiology
  • Monoclonal Antibody
  • Transplantation
  • United States
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom
  • Drug Approval

“Etanercept - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Cutaneous Lupus Erythematosus in 7 Major Markets. A detailed picture of the Etanercept in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan,...

  • Monoclonal Antibody
  • Europe
  • Japan
  • World
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom
  • United States
  • Health Expenditure

Major players in the gene therapy market are Novartis AG, Bluebird Bio, Inc., Spark Therapeutics, Inc., Audentes Therapeutics, Voyager Therapeutics, Applied Genetic Technologies Corporation, UniQure N.V., Celgene Corporation, Cellectis S.A., and Sangamo Therapeutics. The global gene therapy market is expected to grow from $3.18 billion...

  • Gene Therapy
  • World
  • United States
  • United Kingdom
  • Cancer Incidence
  • Cancer Mortality

MGB Biopharma Ltd (MGB Biopharma) is a a biopharmaceutical company which develops novel class of anti-infectives using Minor Groove Binder (MGBs) compounds.

  • Biopharmaceutical
  • Pharmaceutical
  • Healthcare
  • Scotland
  • United Kingdom

## BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

  • Cell Therapy
  • Regenerative Medicine
  • United States
  • World
  • North America
  • Europe
  • United Kingdom
  • India
  • APAC
  • Health Expenditure
  • Stem Cell Transplantation

Report Scope The current report provides detailed exposure of media, sera and reagents used in cell culture.This report highlights the current and future market potential of culture media, sera and reagents used in cell culture along with a detailed analysis of the competitive environment, regulatory scenario, and technological...

  • Cell Therapy
  • World
  • Europe
  • North America
  • APAC
  • China
  • Japan
  • Middle East
  • United States
  • Mexico
  • United Kingdom
  • Canada
  • France
  • Germany
  • India

Arbutus Biopharma Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018

  • Hepatitis
  • Biopharmaceutical
  • Pharmaceutical
  • Drug Development
  • Healthcare
  • United Kingdom
  • Drug Approval

Akeso Biopharma Inc (Akeso) is a clinical-stage biopharmaceutical company that focus on in-house discovery and development of mono and bi-specific antibody drugs.

  • Therapy
  • Monoclonal Antibody
  • Drug Development
  • Protein Therapy
  • Infectious Disease
  • World
  • United Kingdom
  • Sweden
  • Pharmaceutical Registrations
  • Drug Approval

Stemedica San Diego County California Cell Therapy Biopharmaceutical Regenerative Medicine Pharmaceutical

  • Cell Therapy
  • Europe
  • United Kingdom
  • France
  • Chronic Disease Prevalence
  • Cause-Specific Mortality Rate

‘Gene and Cell Therapies targeting CNS Disorders – Market Insights and Market Forecast – 2026’ report delivers an in-depth understanding of the market trends of Gene and Cell Therapies targeting CNS Disorders in in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Gene and Cell Therapies targeting...

  • Cell Therapy
  • Mental Health
  • World
  • Spain
  • France
  • Germany
  • United States
  • Italy
  • United Kingdom
  • Health Expenditure

Akeso Inc (Akeso) is a clinical-stage biopharmaceutical company that focus on in-house discovery and development of mono and bi-specific antibody drugs.

  • Pathology
  • Pharmaceutical
  • Therapy
  • Healthcare
  • Drug Development
  • Monoclonal Antibody
  • Protein Therapy
  • Infectious Disease
  • World
  • United Kingdom
  • Sweden
  • Drug Approval
  • Pharmaceutical Registrations

‘B-cell Non-Hodgkin’s Lymphoma—Market Insights, Epidemiology, and Market Forecast—2028’ report deliver an in-depth understanding of the disease, historical and forecasted epidemiology as well as the market trends of B-cell NHL in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. Geography...

  • Immunotherapy
  • Lymphoma
  • Spain
  • Germany
  • France
  • Japan
  • United States
  • Italy
  • United Kingdom
  • Stem Cell Transplantation

Immune Response BioPharma Inc

  • Therapy
  • Monoclonal Antibody
  • Drug Development
  • Protein Therapy
  • Healthcare
  • World
  • United Kingdom
  • Sweden
  • Pharmaceutical Registrations
  • Drug Approval

The Europe Cleanroom Technology Market would witness market growth of 3.5% CAGR during the forecast period (2019-2025). It is projected that technical advancements in cleanroom technology would support the growth of the sector. Cleanroom technology has evolved from traditional cleanrooms to modular versatile technology that benefits...

  • Pharmaceutical
  • HVAC
  • Biotechnology
  • Biopharmaceutical
  • Diagnostics
  • Europe
  • United Kingdom

UGA Biopharma GmbH

  • Biopharmaceutical
  • Pharmaceutical
  • Healthcare
  • United Kingdom
  • Manufacturing Output
  • Capacity Utilization

‘Adeno-Associated Virus (AAV) Vector Based Gene Therapy - Market Insights, Epidemiology and Market Forecast—2030’ report delivers an in-depth understanding of the AAV Vector Based Gene Therapy, historical and forecasted epidemiology as well as the AAV Vector Based Gene Therapy market trends in the United States, EU5 (Germany, France, Italy,...

  • Gene Therapy
  • United States
  • Germany
  • Spain
  • France
  • Japan
  • Italy
  • United Kingdom
  • Medical Technology Density
  • Hospital Admission

The company offers a wide range of products including prescription medicines, consumer health care products, animal health care products and biopharmaceuticals.

  • Cancer
  • Therapy
  • Oncology
  • Prostate Cancer
  • Bladder Cancer
  • Oncology
  • Cell Therapy
  • Genomics
  • Pancreatic Cancer
  • World
  • United Kingdom
  • Prescription Drug Sales

United Kingdom Biopharmaceutical

  • Biopharmaceutical
  • Pharmaceutical
  • Healthcare
  • United Kingdom
  • High Net Worth Individuals Number
  • Pharmaceutical Exports

Summary AstraZeneca plc (AstraZeneca) is a biopharmaceutical company that endeavors to discover, produce and commercialize a wide range of prescription drugs.It focuses on therapy areas such as respiratory; cardiovascular and renal and metabolic diseases; and cancer, besides autoimmune, infection and neurological diseases. It...

  • Biopharmaceutical
  • Prescription Drug
  • Pharmaceutical
  • Europe
  • Africa
  • APAC
  • North America
  • Cambridgeshire
  • Middle East
  • Australasia
  • Asia

Autolus Therapeutics Plc (Autolus), formerly Autolus Therapeutics Limited is a clinical-stage biopharmaceutical company which offers programmed T cell immunotherapies for the treatment of hematological cancers and solid tumors.

  • Immunotherapy
  • Therapy
  • Healthcare
  • Pharmaceutical
  • United Kingdom
  • Manufacturing Output
  • Health Provider Density

This acquisition enables PolyTherics to provide a suite of services and technologies for development of biopharmaceuticals.

  • Immunotherapy
  • Pharmaceutical
  • Healthcare
  • United Kingdom

Evaluation of Therapeutic Segments Including Monoclonal Antibodies, Insulin, Fusion Proteins, Interferons and Gene Therapies; Prediction of Leading National Markets (US, Japan, EU5 and BRIC); Investigation of Top Products Including Humira, Remicade, Lantus and Enbrel; and Assessment of R&D Including Sirukumab and NurOwn Report...

  • Biopharmaceutical
  • Pharmaceutical
  • Regenerative Medicine
  • Gene Therapy
  • Monoclonal Antibody
  • Japan
  • United States
  • BRIC
  • Spain
  • China
  • France
  • Germany
  • Russia
  • India
  • Italy
  • Brazil
  • United Kingdom

Celyad SA, a bio-pharmaceutical company focused on the development of CAR-T cell-based therapies, has entered into an exclusive agreement with Horizon Discovery Group plc, a genomics company that develops and supplies patient-relevant drug discovery tools and diagnostic reference material, to generate non-gene edited allogeneic CAR-T candidate, CYAD-##, using the TIM (TCR Inhibiting Molecule).

  • Cell Therapy
  • Genomics
  • Drug Development
  • Oncology
  • United Kingdom
  • Direct Sales
  • Number Of R&D Personnel

Hemispherx Biopharma, Inc. said it is expanding its partnership with myTomorrows to supply Ampligen for pancreatic cancer patients in Canada under a Special Access Program (SAP).

  • Orthopedics
  • Clinical Trial
  • Gene Therapy
  • Clinical Research
  • Pancreatic Cancer
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
  • Direct Sales
  • Manufacturing Orders

Autolus Therapeutics Plc (Autolus), formerly Autolus Therapeutics Limited is a clinical-stage biopharmaceutical company which offers programmed T cell immunotherapies for the treatment of hematological cancers and solid tumors.

  • Pharmaceutical
  • Immunotherapy
  • Therapy
  • Healthcare
  • United Kingdom
  • Manufacturing Output
  • Health Provider Density

Nightstar Limited (NightstaRx), a biopharmaceutical company, has raised USD## million in series B financing round.

  • Therapy
  • Gene Therapy
  • Healthcare
  • Pharmaceutical
  • United Kingdom
  • Number Of R&D Personnel
  • Biologics Sales

Cell Therapy Catapult Ltd Cell and Gene Therapy Catapult Therapeutics Ltd United Kingdom Greater London Northern Europe England Cell Therapy Regenerative Medicine Gene Therapy Biopharmaceutical

  • Cell Therapy
  • Gene Therapy
  • United Kingdom
  • Biologics Production